Nelfinavir Impairs Glycosylation of Herpes Simplex Virus 1 Envelope Proteins and Blocks Virus Maturation
Nelfinavir (NFV) is an HIV-1 aspartyl protease inhibitor that has numerous effects on human cells, which impart attractive antitumor properties. NFV has also been shown to have in vitro inhibitory activity against human herpesviruses (HHVs). Given the apparent absence of an aspartyl protease encoded...
Saved in:
Main Authors: | Soren Gantt, Eliora Gachelet, Jacquelyn Carlsson, Serge Barcy, Corey Casper, Michael Lagunoff |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Advances in Virology |
Online Access: | http://dx.doi.org/10.1155/2015/687162 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Herpes Simplex Virus Pneumonia: Importance of Aspiration Etiology
by: Kentaro Odani, et al.
Published: (2019-01-01) -
Evasion of Early Antiviral Responses by Herpes Simplex Viruses
by: Paula A. Suazo, et al.
Published: (2015-01-01) -
Mucosal Herpes Immunity and Immunopathology to Ocular and Genital Herpes Simplex Virus Infections
by: Aziz Alami Chentoufi, et al.
Published: (2012-01-01) -
Herpes Simplex Virus Type 1 is the Leading Cause of Genital Herpes in New Brunswick
by: Richard Garceau, et al.
Published: (2012-01-01) -
Herpes Simplex Virus Latency: The DNA Repair-Centered Pathway
by: Jay C. Brown
Published: (2017-01-01)